Risk Intervention Study: Cisapride

5/23/01


Click here to start


Table of Contents

Risk Intervention Study: Cisapride

Topics for Today’s Discussion

Cisapride’s Regulatory History

Cisapride’s Regulatory History

Cisapride’s Regulatory History

Study Objective

Methods

Study Sites

Cohorts Before and After Labeling Changes through 6/98

Results: Contraindicated Drug or Disease

Conclusion

Study Group

Summary / Considerations

Future Directions

Future Directions

Future Directions

Possible Next Steps

Possible Next Steps

Back Up Slides

PPT Slide

Contraindicated Comorbidity

Author: david graham